First Foundation Advisors Dexcom Inc Transaction History

First Foundation Advisors

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $51,896 - $61,337	-499 Reduced 18.79%	2,157 $250,000
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $3,994 - $5,765	47 Added 1.8%	2,656 $300,000
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $199,197 - $245,715	2,609 New	2,609 $210,000
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $199,197 - $245,715	2,609 New	2,609 $210,000
Q2 2022 Aug 12, 2022	SELL	$67.99 - $132.89 $70,233 - $137,275	-1,033 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$94.08 - $130.2 $11,289 - $15,623	120 Added 13.14%	1,033 $528,000
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $22,467 - $28,167	-173 Reduced 15.93%	913 $490,000
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $13,979 - $18,756	131 Added 13.72%	1,086 $594,000
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $7,208 - $9,605	89 Added 10.28%	955 $408,000
Q1 2021 May 18, 2021	BUY	$84.79 - $104.74 $10,344 - $12,778	122 Added 16.4%	866 $311,000
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $58,032 - $77,748	744 New	744 $275,000

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

Stay updated on First Foundation Advisors with notifications on news.